Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle

Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tissue engineering. Part A 2011-07, Vol.17 (13-14), p.1747-1758
Hauptverfasser: Koning, Merel, Werker, Paul M.N., van Luyn, Marja J.A., Harmsen, Martin C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1758
container_issue 13-14
container_start_page 1747
container_title Tissue engineering. Part A
container_volume 17
creator Koning, Merel
Werker, Paul M.N.
van Luyn, Marja J.A.
Harmsen, Martin C.
description Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC). In vivo , SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC in vivo , SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC in vitro . During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of NCAM . The gene expression of the myogenic transcription factors PAX7 , MYF5 , and MYOD was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins MYL1 and MYL3 was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis in vitro , at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool.
doi_str_mv 10.1089/ten.tea.2010.0624
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_883030563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A274871180</galeid><sourcerecordid>A274871180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</originalsourceid><addsrcrecordid>eNqNkkFrHCEUx6W0NMm2H6CXIs2hp93qqKPb23ZJu4WEBpJCb-LMPBfTGd2qA9ljv3kcNgmkFFpFnzx-_z8-fQi9oWRBiVp-yOAXGcyiIiVD6oo_Q8d0yeScMfHj-eOZ0yN0ktINITWppXyJjirKmaprcYx-b_a7cOsMvoxhCBnSdOidhWiyCx4HizfjYDy-2IcteNfiK5Oh710GvC4xfcQrfFmEPjvT40_gwZo2h4idx9cupRHwmd86DxCd305-Vz-hh1zgizG1PbxCL6zpE7y-jzP0_fPZ9XozP__25et6dT5vhWJ5DpZLJqolU6KjhgimpLBlt4TXrCOqEi21qulIQ6qmUYpXpOIN4aAay6mSbIbeH3x3MfwaIWU9uNSWEoyHMCatFCOMiJr9m5RMErEsghl69wd5E8boSxkTxGQZvECnB2hretDO25CjaSdLvaokV5JSRQq1-AtVZgeDa0N5VlfyTwT0IGhjSCmC1bvoBhP3mhI9tYcun1KW0VN76Kk9iubt_X3HZoDuUfHQDwWQB2BKG-97Bw3E_B_Wd_p7yBI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>873377774</pqid></control><display><type>article</type><title>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Koning, Merel ; Werker, Paul M.N. ; van Luyn, Marja J.A. ; Harmsen, Martin C.</creator><creatorcontrib>Koning, Merel ; Werker, Paul M.N. ; van Luyn, Marja J.A. ; Harmsen, Martin C.</creatorcontrib><description>Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC). In vivo , SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC in vivo , SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC in vitro . During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of NCAM . The gene expression of the myogenic transcription factors PAX7 , MYF5 , and MYOD was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins MYL1 and MYL3 was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis in vitro , at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool.</description><identifier>ISSN: 1937-3341</identifier><identifier>EISSN: 1937-335X</identifier><identifier>DOI: 10.1089/ten.tea.2010.0624</identifier><identifier>PMID: 21438665</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adult ; Aged ; Biomarkers - metabolism ; Cell Differentiation - drug effects ; Cell Hypoxia - drug effects ; Cell proliferation ; Cell Proliferation - drug effects ; Cell Shape - drug effects ; Cells ; Cells, Cultured ; Desmin - metabolism ; Female ; Fibroblasts - cytology ; Fibroblasts - drug effects ; Gene Expression Regulation - drug effects ; Humans ; Hypoxia ; Male ; Middle Aged ; Models, Biological ; Muscle, Skeletal - cytology ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - physiology ; Muscles ; Muscular system ; Neural Cell Adhesion Molecules - metabolism ; Original Articles ; Oxygen - pharmacology ; PAX7 Transcription Factor - metabolism ; Physiological aspects ; Satellite Cells, Skeletal Muscle - cytology ; Satellite Cells, Skeletal Muscle - drug effects ; Satellite Cells, Skeletal Muscle - metabolism ; Skeletal system ; Tissue engineering ; Tissue Engineering - methods</subject><ispartof>Tissue engineering. Part A, 2011-07, Vol.17 (13-14), p.1747-1758</ispartof><rights>2011, Mary Ann Liebert, Inc.</rights><rights>COPYRIGHT 2011 Mary Ann Liebert, Inc.</rights><rights>(©) Copyright 2011, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</citedby><cites>FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21438665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koning, Merel</creatorcontrib><creatorcontrib>Werker, Paul M.N.</creatorcontrib><creatorcontrib>van Luyn, Marja J.A.</creatorcontrib><creatorcontrib>Harmsen, Martin C.</creatorcontrib><title>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</title><title>Tissue engineering. Part A</title><addtitle>Tissue Eng Part A</addtitle><description>Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC). In vivo , SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC in vivo , SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC in vitro . During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of NCAM . The gene expression of the myogenic transcription factors PAX7 , MYF5 , and MYOD was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins MYL1 and MYL3 was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis in vitro , at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - metabolism</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Hypoxia - drug effects</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Shape - drug effects</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Desmin - metabolism</subject><subject>Female</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - drug effects</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Muscle, Skeletal - cytology</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - physiology</subject><subject>Muscles</subject><subject>Muscular system</subject><subject>Neural Cell Adhesion Molecules - metabolism</subject><subject>Original Articles</subject><subject>Oxygen - pharmacology</subject><subject>PAX7 Transcription Factor - metabolism</subject><subject>Physiological aspects</subject><subject>Satellite Cells, Skeletal Muscle - cytology</subject><subject>Satellite Cells, Skeletal Muscle - drug effects</subject><subject>Satellite Cells, Skeletal Muscle - metabolism</subject><subject>Skeletal system</subject><subject>Tissue engineering</subject><subject>Tissue Engineering - methods</subject><issn>1937-3341</issn><issn>1937-335X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkkFrHCEUx6W0NMm2H6CXIs2hp93qqKPb23ZJu4WEBpJCb-LMPBfTGd2qA9ljv3kcNgmkFFpFnzx-_z8-fQi9oWRBiVp-yOAXGcyiIiVD6oo_Q8d0yeScMfHj-eOZ0yN0ktINITWppXyJjirKmaprcYx-b_a7cOsMvoxhCBnSdOidhWiyCx4HizfjYDy-2IcteNfiK5Oh710GvC4xfcQrfFmEPjvT40_gwZo2h4idx9cupRHwmd86DxCd305-Vz-hh1zgizG1PbxCL6zpE7y-jzP0_fPZ9XozP__25et6dT5vhWJ5DpZLJqolU6KjhgimpLBlt4TXrCOqEi21qulIQ6qmUYpXpOIN4aAay6mSbIbeH3x3MfwaIWU9uNSWEoyHMCatFCOMiJr9m5RMErEsghl69wd5E8boSxkTxGQZvECnB2hretDO25CjaSdLvaokV5JSRQq1-AtVZgeDa0N5VlfyTwT0IGhjSCmC1bvoBhP3mhI9tYcun1KW0VN76Kk9iubt_X3HZoDuUfHQDwWQB2BKG-97Bw3E_B_Wd_p7yBI</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Koning, Merel</creator><creator>Werker, Paul M.N.</creator><creator>van Luyn, Marja J.A.</creator><creator>Harmsen, Martin C.</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20110701</creationdate><title>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</title><author>Koning, Merel ; Werker, Paul M.N. ; van Luyn, Marja J.A. ; Harmsen, Martin C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - metabolism</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Hypoxia - drug effects</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Shape - drug effects</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Desmin - metabolism</topic><topic>Female</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - drug effects</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Muscle, Skeletal - cytology</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - physiology</topic><topic>Muscles</topic><topic>Muscular system</topic><topic>Neural Cell Adhesion Molecules - metabolism</topic><topic>Original Articles</topic><topic>Oxygen - pharmacology</topic><topic>PAX7 Transcription Factor - metabolism</topic><topic>Physiological aspects</topic><topic>Satellite Cells, Skeletal Muscle - cytology</topic><topic>Satellite Cells, Skeletal Muscle - drug effects</topic><topic>Satellite Cells, Skeletal Muscle - metabolism</topic><topic>Skeletal system</topic><topic>Tissue engineering</topic><topic>Tissue Engineering - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koning, Merel</creatorcontrib><creatorcontrib>Werker, Paul M.N.</creatorcontrib><creatorcontrib>van Luyn, Marja J.A.</creatorcontrib><creatorcontrib>Harmsen, Martin C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Tissue engineering. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koning, Merel</au><au>Werker, Paul M.N.</au><au>van Luyn, Marja J.A.</au><au>Harmsen, Martin C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</atitle><jtitle>Tissue engineering. Part A</jtitle><addtitle>Tissue Eng Part A</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>17</volume><issue>13-14</issue><spage>1747</spage><epage>1758</epage><pages>1747-1758</pages><issn>1937-3341</issn><eissn>1937-335X</eissn><abstract>Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC). In vivo , SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC in vivo , SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC in vitro . During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of NCAM . The gene expression of the myogenic transcription factors PAX7 , MYF5 , and MYOD was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins MYL1 and MYL3 was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis in vitro , at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>21438665</pmid><doi>10.1089/ten.tea.2010.0624</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1937-3341
ispartof Tissue engineering. Part A, 2011-07, Vol.17 (13-14), p.1747-1758
issn 1937-3341
1937-335X
language eng
recordid cdi_proquest_miscellaneous_883030563
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Aged
Biomarkers - metabolism
Cell Differentiation - drug effects
Cell Hypoxia - drug effects
Cell proliferation
Cell Proliferation - drug effects
Cell Shape - drug effects
Cells
Cells, Cultured
Desmin - metabolism
Female
Fibroblasts - cytology
Fibroblasts - drug effects
Gene Expression Regulation - drug effects
Humans
Hypoxia
Male
Middle Aged
Models, Biological
Muscle, Skeletal - cytology
Muscle, Skeletal - drug effects
Muscle, Skeletal - physiology
Muscles
Muscular system
Neural Cell Adhesion Molecules - metabolism
Original Articles
Oxygen - pharmacology
PAX7 Transcription Factor - metabolism
Physiological aspects
Satellite Cells, Skeletal Muscle - cytology
Satellite Cells, Skeletal Muscle - drug effects
Satellite Cells, Skeletal Muscle - metabolism
Skeletal system
Tissue engineering
Tissue Engineering - methods
title Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T00%3A05%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypoxia%20Promotes%20Proliferation%20of%20Human%20Myogenic%20Satellite%20Cells:%20A%20Potential%20Benefactor%20in%20Tissue%20Engineering%20of%20Skeletal%20Muscle&rft.jtitle=Tissue%20engineering.%20Part%20A&rft.au=Koning,%20Merel&rft.date=2011-07-01&rft.volume=17&rft.issue=13-14&rft.spage=1747&rft.epage=1758&rft.pages=1747-1758&rft.issn=1937-3341&rft.eissn=1937-335X&rft_id=info:doi/10.1089/ten.tea.2010.0624&rft_dat=%3Cgale_proqu%3EA274871180%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=873377774&rft_id=info:pmid/21438665&rft_galeid=A274871180&rfr_iscdi=true